Skip to content
thestock.space

Shree Pacetronix (BSE: SHREEPAC) had a P/E of 19.5× on 6 Nov 2026, below the industry P/E of 28.6×, and the shares are 39% below their 52-week high. Sales grew 2.2% a year over 3 years while net profit fell 1.2%; its ROCE of 25% is the highest among the 7 largest Medical Instruments & Supplies peers. Debt is 0.15× equity. It is a small-cap company with a market cap of ₹64 Cr, ranked 8th of 11 Medical Instruments & Supplies companies by market cap; the shares fell 39% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹175.00
Day high
₹180.00
Day low
₹170.00
Prev. close
₹169.45
Volume
871

Health check

3 good · 3 to check
  • ReturnsBehind

    −38.5% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 19.5 vs industry 28.6.

  • GrowthSlow

    Sales +2.2%, profit −1.2% a year over 3 years.

  • ProfitabilityStrong

    ROCE 25.0% vs peer median 11.5%.

  • Balance sheetSolid

    Debt 0.15× equity, interest covered 11.4×, Piotroski 7 of 9.

  • Red flags2 to check

    Quarterly sales down 8.4% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Instruments & Supplies

10 listed peers. Screen the industry

Small cap

₹64 Cr, #8 of 11 in its industry by size.

Defensive

Beta 0.23 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹21 Cr · profit ₹3 Cr
Market cap
₹64 Cr
Small cap
P/E
19.5
Industry 28.6
Price to book
3.41
Peers 5.26
Dividend yield
0.00%
ROE
19.7%
Peers 10.5%
ROCE
25.0%
Peers 11.5%
Debt to equity
0.15
Debt ₹2.68 Cr
EPS (TTM)
₹8.73
OPM (TTM)
24.8%
Net margin 15.3%
Sales growth
−8.4%
Latest quarter vs a year ago
Profit growth
+13.7%
Latest quarter vs a year ago
Price to sales
3.01
EV/EBITDA 12.3

Strengths and risks

Strengths

  • Return on equity of 19.7%.
  • Return on capital employed of 25.0%.
  • P/E of 19.5 against an industry P/E of 28.6.

Risks to check

  • Quarterly sales down 8.4% on a year ago.
  • 39% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Shree Pacetronix

Shree Pacetronix Limited, through its subsidiary, manufactures and sells implantable cardiac pacemakers in India and internationally. The company offers pacemakers, an anti-bradycardia implantable device for permanent ventricular or atrial pacing applications; and pacing leads that consist of one or more conductors insulated with a sheath of material, such as silicone rubber, polyethylene, and polyurethane for use with pulse generators for long term…

Headquarters
Pithampur
Employees
132
Sector
Healthcare
ISIN
INE847D01010
Website
pacetronix.com

Price range

52 weeks

₹90.00₹280.00

Today

₹170.00₹180.00
Avg volume (3M)
4.1K
1-year return
minus 38.5%
From 52-week high
minus 39.3%

Peers · Medical Instruments & Supplies

Compare with peersScreen the whole industry
Company
LENSKARTLenskart Solutions724.75plus 0.89%1,25,562160.713.487.2%6.7%20.8%––0.00%plus 79.8%
AGARWALEYEDr. Agarwal's Health Care516.35plus 0.91%16,37394.17.669.7%6.8%15.0%26.9%12.3%0.00%minus 0.7%
POLYMEDPoly Medicure1,612.30plus 0.63%16,34351.45.2613.3%11.0%15.2%18.8%21.6%0.22%minus 18.1%
TARSONSTarsons Products316.95minus 0.46%1,686151.72.644.8%2.3%−0.9%14.3%−43.8%0.00%plus 10.9%
LAXMIDENTLLaxmi Dental196.42minus 0.05%1,08134.84.4411.5%12.8%16.4%19.5%–0.00%minus 37.9%
PREVESTPrevest Denpro397.85minus 3.85%47822.03.8321.9%17.8%34.8%12.4%9.3%0.25%minus 21.2%
QMSMEDIQMS Medical Allied Services168.66minus 0.69%32628.65.6818.4%10.5%12.0%18.4%16.7%0.30%plus 75.0%
SHREEPACShree Pacetronix170.00plus 0.32%6419.53.4125.0%19.7%24.8%2.2%−1.2%0.00%minus 38.5%
Median of 7 peers–−0.05%1,68651.45.2611.5%10.5%15.2%18.6%12.3%0.00%−0.7%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
5.36.64.35.44.9
4.24.63.93.73.7
1.220.41.61.2
21.7%30.5%10.0%30.4%24.2%
00000
0.10.10.10.10
0.20.20.20.20.2
0.91.80.21.41
25.3%25.2%63.6%21.3%25.3%
0.71.30.11.10.8
1.853.640.162.991.94

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+2.2%
Profit CAGR 3Y
−1.2%
EPS CAGR 3Y
−2.2%
ROE
19.7%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
20.32216.821.6
–+8.8%minus 23.8%+28.8%
14.617.214.516.3
5.64.92.35.3
27.7%22.0%13.9%24.5%
00.10.10
0.20.40.60.4
0.600.80.7
−0.20––
4.64.614.2
29.4%27.4%28.1%25.4%
3.33.40.73.1
–+3.0%minus 77.7%+319.2%
9.069.332.088.47

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
3.63.63.63.7
6.19.410.214.4
2.24.35.12.7
4.74.44.24.9
16.521.72325.7
4.75.14.74.6
1.70.90.90.9
0.30.50.50.5
0.80.81.11.5
914.515.818.2
16.521.72325.7

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1.7−0−02.9
−1.4−0−0−0.8
−1.100.2−1.6
−0.800.10.5
−1.2−0−0.7−1.2
0.5−0−0.71.7

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you